-
71.发明申请公开(公告)号：US20200263211A1
公开(公告)日：2020-08-20
申请号：US16548093
申请日：2019-08-22
Inventor： Jeong Chan JOO , Hee Taek KIM , Bong Keun SONG , Kyoung Hee KANG , Tae Uk KANG , Si Jae PARK
Abstract: The present disclosure pertains to a recombinant Corynebacterium glutamicum strain for production of glutaric acid and a method for production of glutaric acid by using the same. When used to produce glutaric acid, the recombinant Corynebacterium glutamicum strain guarantees an excellent output and allows the selective production of glutaric acid without generation of byproducts, which needs no isolation and purification processes and thus leads to an economical benefit. Consequently, the recombinant strain is useful for production of glutaric acid.
-
72.发明授权公开(公告)号：US10716653B2
公开(公告)日：2020-07-21
申请号：US15538891
申请日：2015-01-07
Applicant: HYUNDAI CALIBRATION & CERTIFICATION TECHNOLOGIES CO., LTD. , KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
Inventor： Kyu Hong Lee , Yong Taek Kwon , Ki Soo Jeon , Jae Seong Lee , Ki Won Seo , Ji Hyun Han
Abstract: The present invention relates to an inhalation toxicity testing chamber device for nanoparticles having a plurality of concentrations. The present invention provides an inhalation toxicity testing chamber device for nanoparticles having a plurality of concentrations, which: can supply nanoparticles having different concentrations to particle exposure modules by stacking a plurality of particle exposure modules inside a single chamber housing and by allowing each particle exposure module so as to form an independent space from each other; can perform inhalation toxicity testing of nanoparticles having a plurality of concentrations through a single chamber housing by being capable of exposing the test animals put into each particle exposure module to nanoparticles having different concentrations; can easily perform inhalation toxicity tests of nanoparticles in a small scale laboratory etc. by improving the overall space efficiency as well as reducing the test cost; and can easily perform more diverse and accurate inhalation toxicity tests on nanoparticles by selectively allowing a plurality of particle exposure modules to be in communication with each other or to be formed as an independent space, according to a user's needs, thereby variably applying the space of the particle exposure module without changing the arrangement of the particle exposure module.
-
73.发明申请公开(公告)号：US20200055028A1
公开(公告)日：2020-02-20
申请号：US16349843
申请日：2017-12-28
Inventor： Won Choon CHOI , Yong Ki PARK , Su Jin GONG , Seo Hyun SHIM , Deuk Soo PARK , Ung Gi HONG
IPC: B01J23/652 , B01J23/06 , B01J21/06 , B01J37/02 , B01J38/04 , B01J38/02 , C07C5/32 , C07C9/08 , C07C11/06
Abstract: Disclosed is a catalyst for producing the olefin. The catalyst includes a support including alumina and a sub-support component, and a metal oxide impregnated on the support. The metal oxide includes anyone selected from an oxide of chromium, vanadium, manganese, iron, cobalt, molybdenum, copper, zinc, cerium and nickel; and the sub-support component includes anyone selected from zirconium, zinc and platinum.
-
公开(公告)号：US10526337B2
公开(公告)日：2020-01-07
申请号：US15567692
申请日：2016-06-01
Inventor： Ge Hyeong Lee , Hee-Jong Lim , Heeyeong Cho , Woo Kyu Park , Seong Hwan Kim , Jung Hwan Choi
IPC: C07D487/04 , A61K31/506 , C07D471/04
Abstract: The present invention relates to a heteroaryl derivative represented by Formula 1 wherein , A, R1, R2, R3, R4, and R5 are as defined herein, or a pharmaceutically acceptable salt thereof, a preparation method therefor, and a pharmaceutical composition for preventing or treating diseases associated with PI3 kinases, containing the same as an active ingredient. The heteroaryl derivative according to the present invention has an excellent effect of selectively inhibiting PI3 kinases, thereby being useful in preventing or treating PI3 kinase diseases such as cancers, autoimmune diseases, and respiratory diseases.
-
公开(公告)号：US20190388884A1
公开(公告)日：2019-12-26
申请号：US16468204
申请日：2018-05-01
Inventor： Deuk Soo PARK , Ung Gi HONG , Hyeongchan AHN , Won Choon CHOI , Yong Ki PARK
Abstract: Disclosed is an olefin production method including: pretreating a catalyst by providing reduction gas to an alumina type catalyst to produce olefin from the hydrocarbon including not less than 90 wt % of LPG (Stage 1); producing the olefin by providing the catalyst pretreated at Stage 1 into Riser of Fast Fluidization Regime to dehydrogenate the hydrocarbon (Stage 2); separating the mixture of the produced propylene and the catalyst used at Stage 2, and regenerating the separated catalyst (Stage 3); and recycling the catalyst regenerated at Stage 3 to the process of Stage 1 (Stage 4).
-
Patent Agency Ranking
公开(公告)号：US20190330125A1
公开(公告)日：2019-10-31
申请号：US16471383
申请日：2018-05-01
Inventor： Deuk Soo PARK , Ung Gi HONG , Hyeongchan AHN , Won Choon CHOI , Yong Ki PARK
Abstract: Disclosed is an olefin production method which includes: (a) providing the regenerated catalyst and the hydrocarbon including not less than 90 wt % of LPG into Riser of Fast Fluidization Regime, and dehydrogenating in the presence of an alumina type catalyst; (b) separating an effluent from the dehydrogenation reaction into the catalyst and propylene mixture; (c) stripping to remove the hydrocarbon compound included in the catalyst separated at stage (b); (d) mixing the catalyst stripped at stage (c) with the gas including oxygen, and continuously regenerating it; (e) recycling the catalyst regenerated at stage (d) to stage (a), and providing it again into Riser; and (f) producing propylene product by cooling, compressing and separating propylene mixture of the reaction product separated at stage (b).
-
公开(公告)号：US10434463B2
公开(公告)日：2019-10-08
申请号：US15920962
申请日：2018-03-14
Inventor： Jeong Hoon Kim , Su Young Moon , Bong Jun Chang
IPC: B01D69/02 , B01D53/22 , B01D69/12 , B01D67/00 , C07C7/144 , B01D69/14 , B01D71/02 , B01D71/68 , B01D71/12 , B01D71/60
Abstract: A separation membrane for olefin separation and olefin separation method using the same are provided.
-
公开(公告)号：US20190291075A1
公开(公告)日：2019-09-26
申请号：US16342937
申请日：2017-10-17
Inventor： Ji Woong YOON , Jong San CHANG , Young Kyu HWANG , Kyung Ho CHO , U Hwang LEE , Su Kyung LEE , Ji Sun LEE
IPC: B01J20/22 , B01D53/047 , C07C7/12 , B01J20/34
Abstract: The present invention relates to an organic-inorganic hybrid nanoporous material, maintaining a nanoporous skeleton structure formed by coordination of an organic ligand containing an aromatic compound to a trivalent central metal ion, and further having an intramolecular acid anhydride functional group modified on the aromatic compound of the nanoporous skeleton structure, and thereby exhibits selectivity for olefins, and an adsorbent comprising the same. Specifically, the organic-inorganic hybrid nanoporous material of the present invention exhibits an excellent olefin-selective adsorption capacity through differences in adsorption equilibrium and adsorption rate, and thus can be usefully employed in the separation of C2-C4 hydrocarbons. Further, the olefins adsorbed to the organic-inorganic hybrid nanoporous material can be desorbed by purging of an inert gas which is not liquefied by way of mild vacuum conditions or compression, and thus, the organic-inorganic hybrid nanoporous material can be used to prepare olefins by separating C2-C4 hydrocarbon mixtures.
-
公开(公告)号：US20190284143A1
公开(公告)日：2019-09-19
申请号：US16347480
申请日：2017-11-01
Inventor： Kwangho LEE , Gildon CHOI , Na Ri LEE , Sang Jun PARK , Myoung Eun JUNG , Seong Jin KIM , Kyung-Min YANG , Jihee LEE
IPC: C07D239/48 , C07D405/12 , A61K9/14 , A61K9/20 , A61K9/48 , A61K9/00
Abstract: The present invention relates to novel pyrimidine compounds, a method for preparing the same, and a pharmaceutical composition containing the same as an active ingredient for preventing or treating cancer and inflammatory disease. The novel pyrimidine compounds according to the present invention remarkably inhibits activity of DRAK that inhibits signal systems of TGF-β, which is known to suppress cancer growth, and thus the novel pyrimidine compounds can be used as a pharmaceutical composition for preventing or treating cancer and can be used as a pharmaceutical composition for preventing or treating inflammatory disease.
-
公开(公告)号：US10363602B2
公开(公告)日：2019-07-30
申请号：US15314759
申请日：2015-05-29
Inventor： Young Min Choi , Eun Jung Lee , Sun Ho Jeong , Yeong Hui Seo , Beyong Hwan Ryu , Su Yeon Lee
Abstract: Metal nanoparticles according to the present invention have at least a bimodal size distribution in which the ratio obtained by dividing the area of a first peak, which has the smallest median size on the basis of the median size of peaks in the size distribution of the metal nanoparticles, by the total area of all peaks constituting the size distribution meets 0.4-0.8, and are capped with a capping layer containing an organic acid.
-
-
-
-
-
-
-
-
-
Search Results
940
records
(took 0.056 seconds)
